SoftBank-Backed Chinese Online Drug Retail Platform Dingdang Raises $89M Series B Round

Login to View

Dingdang Medicine Express, a Chinese online drug retail platform, has secured a RMB600 million (US$89.13 million) series B round of financing, according to a statement released on Thursday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in